Home / Companies / Innovent Biologics, Inc. / 25 Jun 2025
Innovent Biologics, Inc.: meeting of 25 Jun 2025
Votes reported on Form N-PX, item by item
86 Form N-PX filers reported votes at the Innovent Biologics, Inc. meeting of 25 Jun 2025. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 97.2% of reported votes for; 9 filers withheld from or voted against at least one nominee.
399 vote records from 83 filers. 2 of the 83 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
12 vote records from 3 filers. 0 of the 2 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
133 vote records from 83 filers. 1 of the 83 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
417 vote records from 83 filers. 60 of the 83 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
248 vote records from 83 filers. 1 of the 83 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
152 vote records from 66 filers. 0 of the 66 filers that marked the item either way voted against management.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
51 vote records from 17 filers. 0 of the 17 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 3. Auditor |
|---|---|---|
| Vanguard | For | For |
| BlackRock and iShares | For | For |
| Fidelity | For | For |
| Dimensional | For | For |
| State Street and SPDR | For | For |
| American Century | For | For |
| Franklin Templeton | For | For |
| Invesco | For | For |
| Equitable | For | For |
| Charles Schwab | For | For |
| Nuveen and TIAA | For | For |
| John Hancock and Manulife | For | For |
| Morgan Stanley, Eaton Vance and Calvert | For | For |
| J.P. Morgan | For | For |
| WisdomTree | For | For |
| PGIM and Prudential | For | For |
| Jackson National funds | For | For |
| Northern Trust and FlexShares | For | For |
| Lincoln Financial | For | For |
| Voya | For | For |
| Russell Investments | For | For |
| BNY Mellon | For | For |
| Capital Group and American Funds | For | For |
| Pacific Life funds | For | For |
| Hartford Funds | For | For |
| Neuberger Berman | For | For |
| American Beacon | For | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Innovent Biologics, Inc. meeting?
86 Form N-PX filers reported votes at the meeting of 25 Jun 2025. On say-on-pay, 0 of 2 voted against management (0.0%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Innovent Biologics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Innovent Biologics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Innovent Biologics, Inc. with a meeting date within three days of 25 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.